pharmaphorum

OCTOBER 13, 2022

Day 2 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview. Click here or the image below to read Reuters: Pharma 2022 Live coverage. The post Reuters Pharma 2022 – Day 2 coverage appeared first on.

Pharma 93

Pharma 93

pharmaphorum

OCTOBER 14, 2022

Day 3 coverage: Click here to read Reuters: Pharma 2022 Day 1 overview. Click here or the image below to read Reuters: Pharma 2022 Day 2 coverage. The post Reuters Pharma 2022 – Day 3 coverage appeared first on.

Pharma 92

Pharma 92

pharmaphorum

NOVEMBER 15, 2022

The post HLTH 2022 – Day 2 appeared first on. A highlight of the afternoon should be hearing from two major healthcare leaders at Amazon: VP of Health Aaron Martin and Chief Medical Officer Nworah Ayogu. Then more pharma voices with panels featuring speakers from Bristol Myers Squibb and AstraZeneca.

Pharma 111

Pharma Healthcare Healthcare Medical 111

European Pharmaceutical Review

JANUARY 17, 2023

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . The number of Phase II/III trials increased from three trials in 2021 to seven trials in 2022.

Medicine 107

Medicine Pharmaceutical 107

Clarivate

FEBRUARY 27, 2024

When global trademark filing activity fell in 2022 , questions rose around what this signified. Applications from Mainland China were up by 9% compared with 2022, while Polish applicants filed 19% more EUTM applications than in 2022. Mainland China – 21,701 (up by 9% compared to 2022) 2.

Marketing 98

Marketing Leads Management 98

pharmaphorum

OCTOBER 20, 2022

When it comes to knowing what’s currently what in digital transformation, be sure to stay tuned and not miss out on coverage of Day Two of Frontiers Health 2022, brought to you LIVE from Milan! The post Frontiers Health 2022 – day 2 appeared first on. Click here or the image below to read Frontiers Health Day 1 coverage.

Healthcare 108

Healthcare Healthcare Sales Marketing 108

pharmaphorum

OCTOBER 31, 2022

Between the 2nd and 4th November, a veritable who’s who of British industry will gather at the Eden Project in Boldeva, Cornwall for Anthropy 2022, the event’s second year. The post Anthropy 2022 appeared first on. Over three days and across 12 stages within multiple biomes, over 130 sessions will take place, including 300 speakers.

Pharma 84

Pharma Pharmaceutical Patients 84

pharmaphorum

OCTOBER 19, 2022

Frontiers Health 2022 in Milan is LIVE! The post Frontiers Health 2022 – day 1 appeared first on. Opening Day One will be Healthware Group’s CEO and founder Roberto Ascione and WTF Health’s founder and host Jessica DaMassa. As the day begins with an energising networking espresso, so shall it close with a ruminating aperitivo.

Networking 99

Networking Management Medical 99

MedCity News

JUNE 8, 2023

A new KFF analysis showed that Medicare spending per person increased to $15,700 in 2022 from $5,800 in 2000, representing a 4.6% average annual growth.

Healthcare 104

Healthcare Healthcare 104

MedCity News

NOVEMBER 23, 2022

Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.

Management 95

Management Patients Physicians 95

European Pharmaceutical Review

MARCH 27, 2023

percent between 2022 and 2027. The research includes historic market data from 2017 to 2021, using 2022 as the base year. In the report, analysts showed North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country. Don Whitley Scientific Ltd.,

Marketing 109

Marketing Pharmaceutical research Pharmaceutical Leads 109

Pharmaceutical Technology

NOVEMBER 2, 2022

Pfizer has reported a 6% decline in revenue to $22.6bn in the third quarter (Q3) of 2022 as against $24bn in the same quarter last year. The reported diluted earnings per share (EPS) for Q3 2022 stood at $1.51, compared to $1.42 The reported diluted earnings per share (EPS) for Q3 2022 stood at $1.51, compared to $1.42

Manufacturing 116

Manufacturing Pharmaceutical 116

Pharmaceutical Technology

FEBRUARY 1, 2023

Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. In the fourth quarter (Q4) of 2022, they increased 13% operationally to $24.3bn compared to $23.8bn in the same quarter last year. For Q4 2022, the reported diluted EPS stood at $0.87 as against $0.59

Pharmaceutical 104

Pharmaceutical Marketing Patients 104

Copyright Clearance Center

JUNE 2, 2023

Across all sectors, US publishing sales in 2022 totaled $28.1 billion, according to the Association of American Publishers.

Sales 98

Sales 98

European Pharmaceutical Review

FEBRUARY 20, 2023

According to a new report on UK life sciences recruitment, there were 11,200 new professional scientific vacancies in the industry across England and Wales in 2022. percent March 2022 was identified as the peak month for scientific jobs in the Pharmaceutical sector (586 vacancies, up 6.2 This represented a year-on-year decrease of -7.4

Recruitment 80

Recruitment Pharmaceutical Marketing Manufacturing 80

Pharmaceutical Technology

NOVEMBER 11, 2022

AstraZeneca has reported an 11% rise in total revenue to $10.98bn in the third quarter (Q3) 2022 as against $9.87bn in the year-ago quarter. For the quarter ending on 30 September 2022, product sales were reported at $10.59bn from $9.7bn in Q3 last year, indicating a growth of 9%.

Food and Drug Administration 96

Food and Drug Administration Food FDA Sales 96

European Pharmaceutical Review

JANUARY 12, 2023

The Sustainable Market Initiative’s (SMI) 2022 Terra Carta Seal , which recognises global companies who are driving innovation and leadership within their industry, has been awarded to pharmaceutical companies GlaxoSmithKline PLC, Sanofi, and Samsung Biologics. ” Biopharma successful in achieving climate-related goals, report finds.

Pharma 97

Pharma Biopharma Manufacturing Government 97

pharmaphorum

NOVEMBER 2, 2022

Wednesday 2 nd November heralds the start of Anthropy 2022 at The Eden Project. The post Anthropy 2022 – Day One appeared first on.

Pharma 82

Pharma Healthcare Healthcare Patients 82

Tribeca Knowledge

NOVEMBER 24, 2022

W ith only weeks left to run in 2022, new drug approvals across the two most important markets for the pharmaceutical industry were in only middling shape. In the US, however, 2022 new drug approvals seemed to be heading for a distinct slump.

Marketing 98

Marketing FDA Medicine Pharmaceutical 98

Pharmaceutical Technology

MARCH 2, 2023

to €22.23bn in fiscal 2022 against €19.68bn in 2021. in group sales in fiscal 2022. For fiscal 2022, Merck’s EBITDA increased by 9.4% Merck presented strong data in Healthcare from its 2022 pipeline about Phase II trials for xevinapant (head and neck cancer) and evobrutinib (multiple sclerosis). organic rise.

Sales 98

Sales Healthcare Healthcare Manufacturing 98

Pharmaceutical Technology

FEBRUARY 10, 2023

AbbVie has reported full-year 2022 net revenues of $58.054bn, representing a 3.3% on a reported basis in global net revenues to $15.121bn for the fourth quarter (Q4) of 2022. AbbVie chairman and CEO Richard Gonzalez said: “2022 was another highly productive year capping a decade of outstanding performance. on a reported basis.

Pharmaceutical 98

Pharmaceutical 98

Pharmaceutical Technology

FEBRUARY 3, 2023

Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. Merck has reported a 22% increase in worldwide sales for the full-year 2022, to $59.28bn from $48.7bn in the prior-year quarter.

Sales 98

Sales Pharmaceutical Sales Engineering Pharmaceutical 98

MedCity News

JANUARY 5, 2023

Fewer new drugs won FDA approvals in 2022 compared to previous years, but some of the products that passed regulatory muster are indicative of trends expected to continue into 2023. For example, more gene and cell therapies are on track to face regulatory decisions in the coming year.

FDA 122

FDA Biopharma Pharma 122

European Pharmaceutical Review

DECEMBER 19, 2022

EMA human medicines committee (CHMP) highlights, November 2022. The post CHMP meeting highlights – December 2022 appeared first on European Pharmaceutical Review.

Medicine 91

Medicine Marketing Patients Medical 91

Pharmaceutical Technology

JULY 29, 2022

Pfizer has reported a 53% operational growth in revenues to $27.7bn in the second quarter (Q2) of 2022 compared to $18.9bn in the same quarter last year. In Q2 2022, Paxlovid, Comirnaty, Eliquis, Prevnar family (Prevnar 13 & 20) in the US and Vyndaqel/Vyndamax were the key drivers in operational growth. as against $0.98

Sales 105

Sales Pharmaceutical Patients 105

Pharmaceutical Technology

FEBRUARY 9, 2023

Teva Pharmaceutical Industries has reported $3.9bn revenue in the fourth quarter (Q4) of 2022, representing a 5% decline in US dollars or a 1% increase in local currency terms, from $4.1bn in the same quarter of the previous year. The post Teva Pharmaceutical reports 5% fall in Q4 2022 revenue appeared first on Pharmaceutical Technology.

Pharmaceutical 96

Pharmaceutical 96

Pharmaceutical Technology

JUNE 29, 2022

The proportion of pharmaceutical companies hiring for AI related positions kept relatively steady in May 2022 compared with the equivalent month last year, with 39.3% in April 2022. When it came to the rate of all job openings that were linked to AI, related job postings dropped in May 2022 from April 2022, with 7.4%

Pharmaceutical 110

Pharmaceutical Recruitment 110

Pharmaceutical Technology

DECEMBER 27, 2022

The healthcare industry saw its share of ups and downs in 2022. The ‘diversity’ buzzword was used by all and sundry in 2022, but beyond the headlines, Clinical Trials Arena investigated what pharma is doing on the ground to improve its record. Tracking the diversity push. Tracking the latest trends. See you in 2023!

Healthcare 122

Healthcare Healthcare Pharma Medical 122

InCrowd

JANUARY 24, 2023

In November of 2022, InCrowd surveyed 500 US physicians to track burnout. In 2022, reports showed that physician burnout had risen to frightening levels. Down from 45% in 2021, only 30% of respondents in 2022 find their profession extremely rewarding. The] health system is hard to navigate and [has] too many admin hurdles.”

Physicians 91

Physicians Management Healthcare Healthcare 91

PharmaVoice

NOVEMBER 21, 2022

Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.

Biopharma 105

Biopharma 105

European Pharmaceutical Review

NOVEMBER 15, 2022

The International Generic and Biosimilar Medicines Association (IGBA)’s new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline suggests how the guideline provides great opportunity to revaluate how regulatory requirements can better advance biosimilar access. WHO Biosimilar Guideline updates.

Medicine 94

Medicine Safety Healthcare Healthcare 94

European Pharmaceutical Review

OCTOBER 19, 2022

The post Microbiology In-Depth Focus 2022 appeared first on European Pharmaceutical Review. Having recently conducted a project to implement more sustainable, reliable and efficient bacterial endotoxin testing across the global Roche corporation, those involved in the project.

Pharmaceutical manufacturing 94

Pharmaceutical manufacturing Pharmaceutical Manufacturing Management 94

Pharmaceutical Technology

FEBRUARY 21, 2023

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast.

Sales 98

Sales Government Leads Medicine 98

pharmaphorum

OCTOBER 27, 2022

Research Partnerships Mariel Metcalfe and Nicole Syms share key insights from the 2022 Living with Endometriosis report, which highlights the experiences of more than 100 patients in the US and how the pharma industry can support them. Read Deep Dive: Patients and Partnerships 2022 in full. Subscribe to future issues of Deep Dive.

Patients 92

Patients Healthcare Healthcare Pharma 92